Novoeight recombinant and Tolterodine Extended-Release Capsules
Determining the interaction of Novoeight recombinant and Tolterodine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
Generic Name: tolterodine
Brand name: Detrol, Detrol LA
Synonyms: Tolterodine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Novoeight recombinant-Tolterodine Tablets
- Novoeight recombinant-Tolterodine Tartrate
- Novoeight recombinant-Tolterodine Tartrate Capsules
- Novoeight recombinant-Tolterodine Tartrate Tablets
- Novoeight recombinant-Tolvaptan
- Novoeight recombinant-Tolvaptan (Jynarque/Jinarc)
- Tolterodine Extended-Release Capsules-Novolin 70/30
- Tolterodine Extended-Release Capsules-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Tolterodine Extended-Release Capsules-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Tolterodine Extended-Release Capsules-Novolin N
- Tolterodine Extended-Release Capsules-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Tolterodine Extended-Release Capsules-Novolin N (Insulin NPH (Vials))